Atlantic Dialysis Management Services
| Primary URL | Location | Industry | www[.]atlanticdialysis[.]com |
Country
United States of America
|
Healthcare
|
|---|
Profile
Atlantic Dialysis Management Services (ADMS) operates as a United States-based entity specializing in the management of dialysis care for patients with end-stage renal disease. The organization coordinates clinical and administrative aspects of hemodialysis treatment, maintaining comprehensive patient records that include personally identifiable information such as names, addresses, social security numbers, and dates of birth, alongside detailed medical data encompassing diagnoses, treatment histories, insurance information, and prescription records. ADMS also appears to engage in or support clinical research activities, as evidenced by its handling of research protocols documenting adverse events in hemodialysis studies, which suggests a role in data stewardship for medical investigations within the dialysis sector. Its services are directed toward facilitating patient care and potentially contributing to clinical knowledge, though the precise market reach and patient volume are not quantified in available materials. The nature of its work places it within the highly regulated healthcare industry, where it manages sensitive health information subject to privacy and security requirements.
The confirmed scope of ADMS's operations is defined by the extensive data categories it processes, indicating a deep integration into the clinical and research workflows of dialysis treatment. Its handling of unredacted clinical reports and medication summaries points to a function that bridges direct patient care with data analysis for research or quality improvement purposes. The 2022 cybersecurity incident, which resulted in the leak of substantial volumes of files by the Snatch Team threat actor, provides stark evidence of the organization's data holdings and the criticality of its information systems. This event revealed a significant discrepancy between ADMS's public characterization of limited access and the actual exfiltration of highly specific personal and medical details, underscoring the sensitivity of the data under its control. No explicit details regarding corporate ownership, subsidiary relationships, or precise geographic footprint beyond the U.S. headquarters are provided, leaving its structural position within the broader healthcare services landscape unspecified. The organization's profile is thus characterized by its specialized focus on dialysis management and associated research data, set against a backdrop of documented challenges in cybersecurity incident transparency and response.
